Kenan Ashouri, MD
Urology · Boynton Beach, FLNPI 1114417862
Payments from drug & device makers
Across 58 payments — averaging $956.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$54K
- Procept Biorobotics Corporation$367
- Ambu Inc.$256
- Calyxo, Inc.$186
- Laborie Medical Technologies Corp.$161
- Myriad Genetic Laboratories, Inc.$161
- plus $476 from 10 others
What the payments were for
- Grants$50,00090%
- Travel & lodging$2,4964%
- Food & beverage$2,9805%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 30 | $53,870 |
| Procept Biorobotics Corporation | 3 | $367 |
| Ambu Inc. | 3 | $256 |
| Calyxo, Inc. | 2 | $186 |
| Laborie Medical Technologies Corp. | 2 | $161 |
| Myriad Genetic Laboratories, Inc. | 2 | $161 |
| Coloplast | 1 | $136 |
| Medtronic | 6 | $116 |
| Valencia Technologies Corporation | 1 | $64 |
| Cycle Pharmaceuticals Inc | 2 | $40 |
| Acera Surgical, Inc. | 1 | $24 |
| Olympus America Inc. | 1 | $23 |
| Teleflex LLC | 1 | $20 |
| Immunitybio, Inc. | 1 | $20 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $17 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$55,476 in reported general payments places this provider in the 85th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $7,458 |
| Trospium Chloride ErTrospium Chloride | 20 | $2,920 |
| Tamsulosin Hcl | 69 | $499 |
| Finasteride | 37 | $308 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $291 |
| Ciprofloxacin Hcl | 24 | $93 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $82 |
| Cephalexin | 31 | $67 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other urology in Boynton Beach
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
- Osvaldo PadronTampa$1.3M
- Mark Anthony GonzalgoMiami$1.1M
- Paul CrispenGainesville$1.1M
- Craig HermanPompano Beach$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.